These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 22339657)

  • 1. Carbon source metabolism and its regulation in cancer cells.
    Yin C; Qie S; Sang N
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):17-35. PubMed ID: 22339657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
    Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?
    Dang CV
    Cell Cycle; 2010 Oct; 9(19):3884-6. PubMed ID: 20948290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
    Dang CV; Le A; Gao P
    Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular determinants of de novo nucleotide biosynthesis in cancer cells.
    Tong X; Zhao F; Thompson CB
    Curr Opin Genet Dev; 2009 Feb; 19(1):32-7. PubMed ID: 19201187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Glutamine Dependency and Metabolic Rescue Protocols.
    Qie S; He D; Sang N
    Methods Mol Biol; 2019; 1928():427-439. PubMed ID: 30725468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.
    Mitsuishi Y; Taguchi K; Kawatani Y; Shibata T; Nukiwa T; Aburatani H; Yamamoto M; Motohashi H
    Cancer Cell; 2012 Jul; 22(1):66-79. PubMed ID: 22789539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.
    Courtnay R; Ngo DC; Malik N; Ververis K; Tortorella SM; Karagiannis TC
    Mol Biol Rep; 2015 Apr; 42(4):841-51. PubMed ID: 25689954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling in control of cell growth and metabolism.
    Ward PS; Thompson CB
    Cold Spring Harb Perspect Biol; 2012 Jul; 4(7):a006783. PubMed ID: 22687276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
    Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
    Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential contribution of key metabolic substrates and cellular oxygen in HIF signalling.
    Zhdanov AV; Waters AH; Golubeva AV; Papkovsky DB
    Exp Cell Res; 2015 Jan; 330(1):13-28. PubMed ID: 25447307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells.
    Meng M; Chen S; Lao T; Liang D; Sang N
    Cell Cycle; 2010 Oct; 9(19):3921-32. PubMed ID: 20935507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
    Lien EC; Lyssiotis CA; Cantley LC
    Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.
    DeBerardinis RJ; Lum JJ; Hatzivassiliou G; Thompson CB
    Cell Metab; 2008 Jan; 7(1):11-20. PubMed ID: 18177721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1 and cancer pathogenesis.
    Semenza GL
    IUBMB Life; 2008 Sep; 60(9):591-7. PubMed ID: 18506846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.
    Dang CV
    Cancer Res; 2010 Feb; 70(3):859-62. PubMed ID: 20086171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
    Chen L; Cui H
    Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.
    Hoxhaj G; Manning BD
    Nat Rev Cancer; 2020 Feb; 20(2):74-88. PubMed ID: 31686003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
    Smolková K; Plecitá-Hlavatá L; Bellance N; Benard G; Rossignol R; Ježek P
    Int J Biochem Cell Biol; 2011 Jul; 43(7):950-68. PubMed ID: 20460169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.